AFP and hepatocellular carcinoma: Elevated AFP is linked to inhibiting the programmed cell death of tumor cells, promoting their proliferation and metastasis, inhibiting the functions of lymphocytes, macrophages, and dendritic cells, inducing malignant transformation, and facilitating the onset of HCC.